Last 32.50 INR
Change Today -1.15 / -3.42%
Volume 471.3K
ISL On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 09/1/14 All times are local (Market data is delayed by at least 15 minutes).

ind-swift laboratories ltd (ISL) Snapshot

Open
33.70
Previous Close
33.65
Day High
34.50
Day Low
32.30
52 Week High
07/3/14 - 57.60
52 Week Low
09/2/13 - 21.60
Market Cap
1.3B
Average Volume 10 Days
401.6K
EPS TTM
-29.11
Shares Outstanding
41.0M
EX-Date
09/20/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IND-SWIFT LABORATORIES LTD (ISL)

Related News

No related news articles were found.

ind-swift laboratories ltd (ISL) Related Businessweek News

No Related Businessweek News Found

ind-swift laboratories ltd (ISL) Details

Ind-Swift Laboratories Limited manufactures and supplies active pharmaceutical ingredients (APIs) and finished dosage forms to the pharmaceutical companies worldwide. The company primarily offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyroidism, analgesic, aromatase inhibitor, nootropic, antihypertensive, antibacterial Quinolone, antidiarrhoeal, alcohol abstinence, antineoplastic, prostatic hyperplasia, and treatment of premature ejaculation; and others, such as glucocorticoids. It also provides products under the urinary incontinence, antiemetic, erectile dysfunction, iron chelating agent, ADHD symptoms, antiretroviral, prostatic hypertrophy, and anticoagulant therapeutic categories. In addition, the company offers products for overactive bladder syndrome and osteoporosis, which are under development stage. Further, it provides menthol and mint derivatives comprising menthol crystals and powder, peppermint oil, mentho oil rectified, mentha oil, dementholised oil, menthones, cis-3-hexenol, menthyl acetate, mint terpenes, mentha piperita oil, spearmint and basil oil, and dihydro myrcenol under the Ind COOL brand. Additionally, the company offers contract research and manufacturing services, including early phase drug development, process development/research, custom chemical synthesis, contract manufacturing, and full time equivalent services for chemistry, analytical, regulatory, and IPR services to innovators, as well as generic and biotech companies. Ind-Swift Laboratories Limited exports its APIs to approximately 50 countries. The company was founded in 1995 and is based in Chandigarh, India.

Founded in 1995

ind-swift laboratories ltd (ISL) Top Compensated Officers

Vice Chairman, Managing Director, Chief Execu...
Total Annual Compensation: 18.0M
Joint Managing Director, Whole Time Director ...
Total Annual Compensation: 18.0M
Executive Director
Total Annual Compensation: 4.8M
Compensation as of Fiscal Year 2013.

ind-swift laboratories ltd (ISL) Key Developments

Ind-Swift Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Ind-Swift Laboratories Ltd. announced unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported total net sales of INR 1,886.128 million compared to INR 2,531.943 million a year ago. Profit from operations before other income, interest and exceptional items was INR 110.569 million compared to INR 193.208 million a year ago. Loss from ordinary activities before tax was INR 171.133 million compared to INR 78.989 million a year ago. Loss from ordinary activities after tax was INR 171.151 million or INR 4.18 per basic and diluted share compared to INR 78.989 million or INR 2.01 per basic and diluted share a year ago.

Ind-Swift Laboratories Ltd. to Report Q1, 2014 Results on Aug 12, 2014

Ind-Swift Laboratories Ltd. announced that they will report Q1, 2014 results on Aug 12, 2014

Ind-Swift Laboratories Ltd., Board Meeting, Aug 12, 2014

Ind-Swift Laboratories Ltd., Board Meeting, Aug 12, 2014. Agenda: To consider issue of equity shares to promoters against the funds infused as per CDR scheme of the Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISL:IN 32.50 INR -1.15

ISL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ISL.
View Industry Companies
 

Industry Analysis

ISL

Industry Average

Valuation ISL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IND-SWIFT LABORATORIES LTD, please visit www.indswiftlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.